Spending $25,000 on an 8,000-Life ACO Panel
You are the clinical pharmacist for an accountable care organization with 8,000 attributed lives. Leadership gives you $25,000 and 10 weeks before influenza season to improve three gaps: influenza vaccination (42% overall), statin use among 1,100 adults with diabetes (68%, with Spanish-preferring patients running roughly 20 percentage points lower), and pneumococcal vaccination in adults over 65 (51%). The ACO has three clinics, a homebound elderly population, and an existing community health worker program that is underused. Most gap closure historically comes from visits that were already scheduled. Data analytics can produce patient lists within one week. Leadership wants a plan with measurable targets, not a list of activities.
1. Where do you put the $25,000, and what do you deliberately not do?
Read the worked answer
Fund the interventions with the shortest path to the largest gap closure, and buy infrastructure rather than one-off events.
Fund (roughly):
- Standing orders plus every-visit vaccination by MAs and nurses at all three clinics - cheapest per dose delivered, and it converts existing visits into closed gaps. This is the single highest-yield item and requires policy and training time, not much money.
- Registry-driven outreach with the CHW program, targeted and language-concordant - concentrate on the Spanish-preferring statin gap and on patients with no visit in 12 months. Generic mass mailings are the classic way to waste this budget.
- Homebound vaccination visits - small numbers, high visibility, and it addresses a group that will otherwise never close.
- Pharmacist statin initiation under protocol for patients with an open gap and a recent visit - low marginal cost, and the pharmacist is already paid for.
Deliberately do not fund: a big off-site flu fair (one day, weather-dependent, and mostly reaches people who would have come in anyway), a patient portal campaign alone (it reaches the already-engaged and worsens the disparity), or new software that cannot be implemented in 10 weeks.
2. How do you address the 20-point statin gap for Spanish-preferring patients without treating it as a separate side project?
Read the worked answer
Treat equity as a measurement problem first. The 20-point gap is an output; possible inputs are language-concordant outreach, uninsured/underinsured status, prior-authorization friction, clinician time pressure, and differential offers of statin therapy during visits.
Actions:
- Stratify every metric you report by language preference and clinic, from day one. A gap that is not on the dashboard does not get managed.
- Deploy CHWs who speak Spanish for the statin outreach calls, with a script that includes what a statin is for and an explicit offer of a pharmacist visit.
- Remove the pharmacist visit language barrier - confirm interpreter access for scheduled visits rather than relying on family members.
- Audit the prescribing step itself: pull 30 charts of Spanish-preferring patients with an open statin gap and check whether the therapy was ever offered and declined, never offered, or offered and blocked by cost. The answer determines the fix - and if it is "never offered," the intervention is clinician-facing, not patient-facing.
Report progress toward closing the gap, not just overall improvement, which can mask a widening disparity.
3. What targets and evaluation design will you commit to at 10 weeks and at 6 months?
Read the worked answer
Commit to process targets at 10 weeks and outcome targets at 6 months - promising outcome movement in 10 weeks would be dishonest.
10 weeks:
- Influenza coverage from 42% to ≥55% overall, with the Spanish-preferring subgroup improving at least as much as the overall panel.
- ≥60% of patients with no visit in 12 months reached by at least one outreach attempt, documented.
- Standing orders active at all three clinics with a documented audit of at least 20 visits per site.
6 months:
- Statin coverage in diabetes from 68% to ≥78%, with the language gap cut by half.
- Pneumococcal coverage from 51% to ≥65%.
Design: use the three clinics' own baseline trends and a run chart with monthly points rather than a single before/after comparison; use the one clinic with the slowest implementation as an internal comparator if rollout is staggered. Include balancing measures - visit cycle time, MA overtime, and no-show rate - because a vaccination program that lengthens every visit will be quietly abandoned by staff. Publish the dashboard monthly to all three sites so the intervention is visible.